Ketamine molecule:

Image from PubChem

Ketamine Clinical Trials


Efficacy of Ketamine Infusion Compared With Traditional Anti-epileptic Agents in Refractory Status Epilepticus- a Pilot Study


To see complete record on clinicaltrials.gov, please visit this link

Id: NCT03115489

Organisation Name: University of Alabama at Birmingham

Overal Status: Recruiting

Start Date: May 4, 2017

Last Update: May 7, 2020

Lead Sponsor: University of Alabama at Birmingham

Brief Summary: The study will investigate the efficacy of the N-methyl-D-aspartate receptor antagonist ketamine as a first line agent in refractory status epilepticus versus traditional general anesthetic agents used for burst suppression that target the gamma-aminobutyric acid adrenergic receptors.

Conditions:
  • Refractory Epilepsy


Total execution time in seconds: 0.20511698722839